By Rishika Sadam and Kashish Tandon Dec 12 (Reuters) - Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg ...

Americans without health insurance could be paying more than 10 times as much for the weight-loss drugs.

It continues to be pounded by competition and challenges coming from numerous directions.

EXCLUSIVE: Novo Inspire Studios, the production outfit co-founded by Wizards Beyond Waverly Place alum David Henrie, is ...

A medical expert warned of the side effects of the newly launched weight loss drug Ozempic.

Global diabetes drug Ozempic (semaglutide) has now been launched in India by Danish pharmaceutical major Novo Nordisk. In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, ...

By Rishika Sadam HYDERABAD, India, Dec 3 (Reuters) - Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug ...

A promising obesity and diabetes drug stumbles in Alzheimer's trials, rattling markets. Did investors overreact, or is this a ...

Novo Nordisk A/S said its high-dose version of blockbuster Wegovy has been cleared by the European Union’s drug advisory board, opening the way for use of a shot that delivers more weight loss than ...

New Delhi, 13 Dec 2025 (ANI): Novo Nordisk launches Ozempic in India for diabetes, weight management at ₹2,200/week ...

We recently published 13 Best ADR Stocks to Invest In. Novo Nordisk A/S (NYSE:NVO) is one of the best ADR stocks. Healthcare ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...